Shanghai, China

Chang Shao


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):

Title: Chang Shao - Innovator in Glycopeptide Compounds

Introduction

Chang Shao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in developing glycopeptide compounds that combat drug-resistant bacteria. His innovative work addresses a critical need in modern medicine, especially in the face of increasing antibiotic resistance.

Latest Patents

Chang Shao holds a patent for glycopeptide compounds that exhibit activity against drug-resistant bacteria. The patent, titled "Glycopeptide compounds having activity of resisting drug-resistant bacteria, and preparation method and application thereof," outlines a novel preparation method and application for these compounds. The glycopeptide compounds conform to a general formula and have shown higher inhibition activity against drug-resistant strains, particularly MRSA and VRE, compared to existing treatments like oritavancin. Furthermore, these compounds demonstrate a safety profile that is superior to that of oritavancin, making them suitable for developing drugs to treat various bacterial infections, including skin and soft tissue infections, meningitis, sepsis, pneumonia, arthritis, peritonitis, bronchitis, and empyema.

Career Highlights

Throughout his career, Chang Shao has worked with notable companies in the biopharmaceutical sector. He has been associated with Shanghai Laiyi Center for Biopharmaceutical R&D Co., Ltd. and Zhejiang Medicine Co., Ltd. His work in these organizations has contributed to advancing research and development in the field of antibiotic resistance.

Collaborations

Chang Shao has collaborated with esteemed colleagues, including Mei Ge and Lingao Ruan. These partnerships have fostered a collaborative environment that enhances innovation and research in biopharmaceuticals.

Conclusion

Chang Shao's contributions to the development of glycopeptide compounds represent a significant advancement in the fight against drug-resistant bacteria. His innovative approach and dedication to research continue to impact the field of medicine positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…